Fresh leukemic cells from patients with adult T cell leukemia (ATL) and some ATL-derived T cell hnes show adhesion to human umbilical vein endothelial cells (HUVECs) mainly through E-selectin, but a proportion of this binding remains unaffected by the addition of combinations of antibodies against known adhesion molecules. By immunizing mice with one of such cell hnes, we estabhshed monoclonal antibodies (mAbs), termed 131 and 315, that recognize a single cell surface antigen (Ag) and inhibit the remaining pathway of the adhesion. These mAbs did not react with normal resting peripheral blood mononuclear cells (PBMC) or most of the cell lines tested except for two other human T cell leukemia virus type I (HTLV-I)-infected T cell hnes. After stimulation with phytohemagglutinin (PHA), PBMC expressed Ag 131/315 transiently, indicating that these mAbs define a T cell activation Ag. Western blotting and immunoprecipitation revealed that Ag 131/315 has an apparent molecular mass of 50 kD. Expression cloning was done by transient expression in COS-7 cells and immunological selection to isolate a cDNA clone encoding Ag 131/315. Sequence analysis of the cDNA indicated that it is identical to human OX40, a member of the tumor necrosis factor/nerve growth factor receptor family. We then found that gp34, the hgand of OX40, was expressed on HUVECs and other types of vascular endothehal cells. Furthermore, it was shown that the adhesion ofCD4 + cells ofPHA-stimulated PBMC to unstimulated HUVECs was considerably inhibited by either 131 or 315. Finally, OX40 transfectants of Kit 225, a human interleukin 2-dependent T cell line, were bound specifically to gp34 transfectants of MMCE, a mouse epithelial cell hne, and this binding was blocked by either 315 or 5A8, an anti-gp34 mAb. These results indicate that the OX40/gp34 system directly mediates adhesion of activated T cells or OX40+-transformed T cells to vascular endothehal cells.
T he trafficking and localization of circulating lymphocytes are regulated by interaction between several pairs of adhesion molecules expressed on lymphocytes and vascular endothehal cells. Tissue specificity of lymphocyte homing has been explained by selective expression of certain sets of adhesion molecules on subsets oflymphocytes as well as tissue-specific high endothehal venules. In mice, the molecules involved in each step of cell adhesion, namely, cell attachment, rolling, and adhesion (sticking), have been identified in different organs and tissues under ex vivo conditions (1) (2) (3) (4) (5) (6) (7) (8) . In humans, where umbilical vein endothehal cells (HUVECs) 1 are commonly used for in vitro experiments, at least three combinations of adhesion molecules are known to be important: LFA-1/intercellular cell adhesion molecules 1 and 2 (ICAM-1,-2); very late antigen 4 (VLA-4)/ vascular cell adhesion molecule 1 (VCAM-1), and several IAbbreviations used in this paper: ATL, adult T cell leukemia; HAEC, human aortic endothehal cell; HDMEC, human dermal microvascular endothehal cell; HUVEC, human umbilical vein endothelial cell; ICAM-1, intercellular adhesion molecule 1; NGF, nerve growth factor; VCAM-1, vascular cell adhesion molecule 1; VLA-4, very late antigen 4.
sialylated Ags such as cutaneous lymphocyte antigen (CLA)/ selectins (9) (10) (11) (12) (13) (14) (15) (16) (17) . It is also indicated that CD6, CD44, and some other molecules can contribute to cell adhesion in certain circumstances (18) (19) (20) (21) (22) .
Although not yet confirmed, there have been reports suggesting the presence of unknown adhesion pathways (23, 24) . Our group previously reported that fresh leukemic cells from patients with adult T cell leukemia (ATL), which often manifests infiltration of malignant cells into a variety of organs such as skin, lung, and intestine, adhere to HUVECs predominantly through E-selectin and VCAM-1 expressed on endothelial cells (25) (26) (27) (28) . Data were presented implying that some part of this adhesion is likely to be mediated by unknown pathway(s) since it was only partially blocked by combinations of mAbs against LFA-1, VLA-4, E-selectin, and other known adhesion molecules. Further characterization was hindered because of limited availability and variation of fresh leukemic cell samples. However, we have recently found that among HTLV-I-infected human T cell lines, ATL-43T (Maeda, M., unpublished results), a human double negative T cell line derived from a patient with ATL, maintains high levels of unknown adhesion activity to HUVECs. It adheres considerably to unstimulated HUVECs, which cannot be blocked by combinations of mAbs against known adhesion molecules.
Recent evidence has disclosed that the phenomenon of cell adhesion is comprised of complicated sequential events involving ligand receptor recognition and subsequent cellular activation. Several cytokines, as well as membranebound costimulatory molecules, augment cell adhesion by upregulating the expression or bindability of certain adhesion molecules (29, 30) . It is now widely accepted that not only cytokines but also adhesion molecules, upon binding to their ligands, give rise to activation signals that lead to the next step of cell adhesion (31) (32) (33) (34) (35) (36) (37) . Furthermore, some cytokines of membrane-bound form have been shown to transmit signals into the cell just like cytokine receptors or costimulatory molecules (38, 39) . These findings as a whole have brought about the situation where the distinction between the adhesion molecule and the costimulatory molecule or between the ligand and the receptor is not always self-evident. The next remaining question is whether the binding of any of the membrane-bound cytokines to their receptors or costimulatory molecules to their ligands directly mediates cell adhesion. Although there have been no definitive reports so far concerning this issue, we think that it is theoretically possible and deserves serious consideration.
In the present study, we developed mAbs against a cell surface Ag on ATL-43T that can inhibit its binding to HUVECs. We characterized these mAbs and cloned a cDNA encoding the antigen molecule recognized by these mAbs, which revealed that it is identical to the human counterpart of rat OX40, a type I transmembrane protein of the TNF/nerve growth factor (NGF) receptor family (40, 41) . Recently, the ligand for OX40 has been identified as gp34, which was initially reported as an Ag expressed preferentially on HTLV-I-infected T cell lines (42) (43) (44) (45) (46) . Here we present evidence that the OX40/gp34 receptor ligand system, which has been described as a pair of TNF receptor/TNF family molecules with costimulatory function, directly mediates the binding of activated T cells to HUVECs.
Materials and Methods
Cells and Culture Conditions. IMDM medium (GIBCO BRL, Gaithersburg, MD) supplemented with 10% heat-inactivated FCS (Summit Biotechnology, Ft. Collins, CO) and 30 t~g/ml tobramycin (Shionogi Pharmaceutical Co., Osaka, Japan) was used throughout this study unless otherwise stated. ATL-43T is an IL-2-dependent HTLV-I-infected human T cell line with a phenotype of CD3 +, CD4-, CD8-established from an ATL patient with intestinal lymphoid involvement. Kit 225 is an IL-2-dependent human T cell line established in our laboratory from a patient with T cell-type chronic lymphocytic leukemia (47) . These cell lines were maintained in medium with 0.5 nM recombinant IL-2 (kindly provided by Shionogi Pharmaceutical Co). PBMC were isolated from heparinized venous blood from normal donors by Ficoll-Paque density gradient centrifugation. PBMC were used freshly or after culture with 0.1 /~g/ml PHA (Murex Diagnostics Limited, Dartford, UK) for 3 d (PHA blasts). CD4 + PHA blasts were prepared by negative selection using immunomagnetic beads (Dynabeads | M-450; Dynal, Oslo, Norway) after incubation with anti-CD8, anti-CD11b, anti-CD14, anti-CD16, and anti-CD20 mAbs. HUVECs were isolated by collagenase digestion according to the procedure ofJaffe et al. (48) . In brief, umbilical cords obtained at normal deliveries were washed with 70% ethanol. The umbilical veins were rinsed with PBS and treated with 0.1% collagenase/PBS for 30 min at room temperature. Subsequently, the collagenase suspension was harvested and HUVECs were obtained by centrifugation. The pelleted cells were suspended in M199 medium (GIBCO BRL) containing 15% FCS and were incubated in a gelatin-coated flask (Coming Glass Works, Coming, NY). After incubation for 6 h at 37~ the endothelial cells were washed and cultured in M199 medium supplemented with 15% FCS, 90 I~g/ml porcine intestinal heparin (Sigma Chemical Co., St. Louis, MO), 30 Ixg/ml endothelial cell growth supplement (Collaborative Research, Inc., Bedford, MA), and antibiotics. HUVEC monolayers were then maintained in M199 medium containing the same additives in the second through the fourth passages and were used in the subsequent assays. The endothelial nature of the cells was confirmed by examining their morphological confluence and by detecting the expression ofvon Willebrand factor using an immunofluorescence assay. Weak expression oflCAM-1 and no expression of VCAM-1 and E-selectin on the resting HUVECs were demonstrated by flow cytometric analysis, whereas the induction of marked expression of these three molecules was noted after activation with 10 ng/ml of IL-113 (kindly provided by Otsuka Pharmaceutical Co., Tokyo, Japan). Human aortic endothelial cells (HAECs) and human dermal microvascular endothelial cells derived from the neonatal foreskin (HDMECs) were purchased from Kurabo (Osaka, Japan) and cultured as described above.
mAbs. mAbs were produced as described elsewhere (49) . In brief, spleen cells from female BALB/c mice immunized with ATL-43T cells were fused with PAl mouse myeloma cells by polyethylene glycol (Sigma Chemical Co.) and subjected to selection in HAT medium (Sigma Chemical Co.). Hybridoma supernatants were screened based on difference in reactivity with original ATL-43T and one of its sublines that had lost adhesion activity to HUVECs after a long-term in vitro culture. The selected su-pematants were then tested for inhibitory effects on the binding of ATL-43T cells to HUVECs. Two independent mAhs, 131 and 315, were found to satisfy these criteria, mAbs 131 and 315 were typed as IgG1 and IgG2a, respectively, using a mouse Ig typing kit (Sigma Chemical Co.) and purified from ascitic fluids using a mouse IgG purification kit (Amersham, Tokyo, Japan). TS1/18 (anti-CD18, the [3 chain of LFA-1), W6/32 (anti-MHC class I, control IgG1), Lym-1 (anti-CD20), OKM-1 (anti-CD11b), and OKT8 (anti-CD8) were also purified from ascitic fluids of the hybridomas obtained from the American Type Culture Collection (Rockville, MD). HP2/1 (anti-CD49d, the ~x chain of VLA-4) was purchased from Immunotech S.A. (Marseille, France). 7A9 (anti-E-selectin) was kindly provided by Dr. W. Newman (Otsuka America Pharmaceutical Inc., Rockville, MD). 3G8 (anti-CD16) was a kind gift of Dr. J.C. Unkeless (Mount Sinai Medical Center, New York). T(.[IR14 (anti-CD14) was purchased from DAKO (Glostmp, Denmark). Anti-gp34 mAbs, 5A8, 8F4, TAG34, and TARM34 were described elsewhere (44) (45) (46) .
Immunofluorescence Staining and Cytometric Analysis. Cells were stained by direct or indirect immunofluorescence and analyzed using a FACScan | (Becton Dickinson Immunocytometry Systems, San Jose, CA) as described previously (50) . Western Blotting. Western blotting was done as described (49) .
Cell Adhesion
Cell lysates from 5 • 106 cells were mixed with SDS sample buffer, boiled for 5 rain, and electrophoresed through a 7.5-10% polyacrylamide gel. Samples were electrotransferred onto sheets of Immobilon-P (polyvinylidene fluoride) (Millipore Corp., Bedford, MA) membranes. The membranes were incubated serially with blocking buffer and with diluted mAb solutions, washed, and then incubated with rabbit peroxidase-conjugated anti-mouse IgG (American Qualex, La Mirada, CA). After washing, the binding of mAb was visualized by the enhanced chemiluminescence detection kit (ECL; Amersham).
Construction ofcDNA Libraries. Poly(A) + RNA was prepared from 10 s ATL-43T cells using a Fast-Track mRNA isolation kit (Invitrogen, San Diego, CA). Ohgo dT-and random hexamer-primed cDNAs were separately synthesized from 2 p~g poly(A) + RNA and BstXI adaptors (Invitrogen) were added to each end. cDNA larger than 1 kb was selected by agarose gel electrophoresis and inserted into the BstXI sites of the expression vector pME18S (kindly provided by Dr. K. Maruyama, Tokyo Medical and Dental University, School of Medicine, Tokyo, Japan) (51 Production of&able Transfectants. cDNAs were subcloned into an expression vector pMKITneo (kindly provided by Dr. K. Maruyama) and transfected into Kit 225 cells or MMCE cells by electroporation. The expression vector for human gp34, pMKITneohgp34, was constructed as follows. The coding sequence of human gp34 was amplified by reverse transcription-PCR amplification of nucleotides 23-617 of human gp34 cDNA using total RNA extracted from MT-2 cells, and the primers 5'-CCCA-GATTGTGAAGATGGAA and 5'-GCCTGGTTTTAGATATT-GCC (55). The PCR product was inserted into pT7Blue vector (Invitrogen). This pT7hgp34 vector was digested with BamHI and XbaI, and "~e resulting cDNA fragment was subcloned into the BamHI/XbaI site of pBluescript | SK+, generating pBluescript-hgp34, pMKITneohgp34 was constructed by transferring a XhoI/NotI fragment of pBluescript-hgp34 within pMKITneo vector in the sense orientation. Cells were centrifuged, resuspended in medium with 1 mg/ml Geneticin (GIBCO BILL), and dispensed 200 Ixl/well in 96-well plates. After 12-14 d, cultures were transferred to 24-well plates. Cells of each well were tested for expression of the relevant antigen by flow cytometry using a FACScan |
Results

Generation of mAbs that Inhibit Binding of ATL-43T Cells to HUVECs. During the screening of HTLV-I-infected
T cell lines for the unknown pathway(s) of adhesion, it was incidentally noticed that ATL-43T cells showed marked adhesion to HUVECs which was not inhibited by addition of any of the mAbs against LFA-1, VLA-4, or E-selectin. After a long-tem~ in vitro culture, ATL-43T cells gradually lost binding activity to HUVECs in comparison with freshly thawed original ATL-43T cells. Therefore, we immunized BALB/c mice with original ATL-43T cells and screened hybridomas based on the quantitative difference Fig. 2 , after stimulation with P HA, expression of Ag 131/315 was detected on day 1, reached maximal levels on days 2-3, and then dechned. Two-color immunofluorescence analyses revealed that the major population expressing Ag 131/315 is the CD4 + subset of PHA-stimulated PBMC, although some CD8 + T cells weakly expressed this Ag (data not shown).
Among the cell lines we tested, ATL-43T, Hutl02, and MT-2, which are all HTLV-I-infected human T cell lines, were found to be positive for this Ag. Other T, B, myelomonocytoid, and (one) squamous cell lines were all negative. These data suggest that Ag 131/315 expression is restricted to activated T cells and may be induced in association with HTLV-I infection.
Biochemical Characterization of Ag 131/315. Western blotting was done to estimate the apparent molecular weight of the molecule recognized by mAbs 131 and 315. Consistent with the data of flow cytometry, a unique 50-kD band was detected in Hutl02, ATL-43T, and PHA-stimulated PBMC by mAb 315 but not in Kit 225 or fresh PBMC (Fig. 3) . Western blotting with mAb 131 gave a band of the same molecular weight (data not shown). Immunoprecipitation from day 3 PHA blasts by mAb 315 also showed a specific 50-kD band; after digestion with peptide N-glycosidase F (New England Biolabs, Beverly, MA), the immunoprecipitates migrated at the apparent molecular mass of r kD, indicating that Ag 131/315 is a glycoprotein containing N-linked carbohydrate (data not shown).
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Isolation and Identification of cDNA Encoding Ag 131/315.
Since it seemed likely that mAbs 131 and 315 recognize an undefined adhesion molecule, we decided to isolate a cDNA clone encoding the Ag molecule by the expression cloning in COS-7 cells. After four cycles oftransfection and immunologic enrichment, individual plasmid clones were transfected by the DEAE-dextran method into COS-7 cells, and after 48 h of culture, the expression of Ag 131/315 was examined by flow cytometry. One of the clones, pME18S315-02, containing a 1.1-kb insert, was found to encode the antigenic epitope recognized by both mAbs 131 and 315 (Fig. 4) . The nucleotide sequence of the insert DNA was determined using an automated sequencer and the sequence was subjected to the homology search. To our surprise, it was identical to the cDNA of the human counterpart of rat OX40 (data not shown). The cDNA we cloned included the sequence from the 5' end to a halfway point before the poly(A) tail of the published human OX40 cDNA. It is likely to encode the integral peptide as reported, which is supported by the fact that Western blotting of stable transfectants of our cDNA gave a band with the same molecular weight as PHA-stimulated normal PBMC (data not shown). 
Anti-OX40 mAbs Inhibit Binding of CD4 +-activated T Cells to Vascular Endothelial Cells.
As mentioned before, OX40 was identified as an activation Ag predominantly expressed on the CD4 + population o f activated T cells (40) . To clarify whether O X 4 0 can function as a cell adhesion molecule for activated T cells, we performed the inhibition study with mAb 315 using CD4 + cells purified from PHA-stimulated PBMC. W e first confirmed that the CD4 + P H A blasts expressed high levels of O X 4 0 in flow cytometric analysis (data not shown). The cells were then analyzed for adhesion activity to both resting and IL-l-stimulated H U V E C s in the presence or absence o f mAbs. Three independent experiments were done with samples from three different healthy volunteers, and a representative experiment is shown in Fig. 5 . A considerable proportion of the cells were bound to unstimulated HUVECs. It was noted that 315 (anti-OX40 mAb) rather than TS1/18 (anti-LFA-1 mAb) inhibited this adhesion and the addition o f both 315 and TS1/18 blocked most of the binding. When IL-l-stimulated HUVECs were used, 315, TS1/18, HP2/1 (anti-VLA-4 mAb), and 7A9 (anti-E-selectin mAb) each showed significant but modest inhibition by itself. Combination of these mAbs clearly increased inhibitory effects on adhesion, and yet the effect of mAb 315 was prominent when added together with the other mAbs. Therefore, the cell adhesion to IL-l-stimulated H U V E C s seems to be mediated by the several pairs of adhesion molecules and a significant part of this adhesion is ascribed to OX40-mediated binding. These data indicated that OX40 is involved in binding of activated CD4 + T cells to HUVECs, whether or not H U V E C s were stimulated. As to other types of vascular endothelial cells, binding of CD4 § P H A blasts to HAECs or H D M E C s and its inhibition by mAb 315 was similarly observed (data not shown).
The Ligand for OX40 on Vascular Endothelial Cells is gp34.
Recent studies have demonstrated that the ligand o f O X 4 0 is gp34, a type II transmembrane protein o f the T N F family that is expressed on some HTLV-I-infected T and activated B cells (42, 43) . Therefore, we next examined if gp34 was expressed on H U V E C s and other types o f vascular endothelial cells. HUVECs, HAECs, and HDMECs were stained with anti-gp34 mAb and analyzed by flow cytometry. As shown in Fig. 6 , not only H U V E C s but also HAECs and H D M E C s expressed considerable levels of gp34 without any stimulation. In fact, no induction or augmentation of gp34 expression was detected after culture of these endothelial cells with IL-113 (data not shown). Western blotting was done to characterize the molecules expressed on H U V E C s that were recognized by 8F4, an anti-gp34 mAb. A specific 34-kD band was seen by 8F4 in HUVECs and MT-2, indicating that H U V E C s express the gp34 molecule o f the same molecular weight as originally described in HTLV-I-infected T cells (Fig. 7) . W e then examined if anti-gp34 Ab could inhibit cell adhesion. As had been expected, 5A8, an anti-gp34 mAb, inhibited binding of ATL- Figure 3 . Western blotting of Ag 315. Cell lysates of Kit 225, Hut102, ATL-43T, fresh PBMC, and PHA-stimnlated PBMC (day 3) were mixed with SDS-sample buffer, boiled for 5 rain, and then applied to electrophoresis through a 7.5% polyacrylamide gel. Proteins were transferred to a sheet of PVDF membrane and the membrane was incubated with 10 Ixg/ml mAb 315. The binding of the mAb was detected as described in Materials and Methods. 43T to HUVECs in a dose-dependent manner (Fig. 8) .
The inhibition by mAb 5A8 was even slightly more efficient than that by mAb 315. These data clearly indicate that gp34 is the major OX40 ligand expressed on HUVECs.
The OX40/gp34 System Directly Mediates Cell Adhesion.
Since both OX40 and gp34 have been reported to transmit stimulatory signals to the cell (42, 43) , it is important to determine if the OX40/gp34 system mediates cell adhesion directly or indirectly by activating other adhesion molecules. To address this question, we made a stable OX40 transfectant of Kit 225 and a stable gp34 transfectant of MMCE, a mouse epithelial cell line (Fig. 9) . Kit 225 exhibits almost no adhesion to MMCE presumably due to the difference in species. As shown in Fig. 10 , OX40-transfected Kit 225 cells that did not bind to parental MMCE cells showed marked adhesion to gp34-transfected MMCE cells, whereas no binding between parental Kit 225 cells and the gp34 transfectants were observed. To further confirm the role of the OX40/gp34 system in cell adhesion, a cell adhesion assay was done using paraformaldehyde-fixed cells (Fig. 11) . Although fixation of either ATL-43T or HUVECs decreased the binding capacity, there remained some specific binding that was blocked by either anti-OX40 or anti-gp34 mAb. These results strongly indicate that the OX40/gp34 system directly mediates binding between OX40 + T cells and gp34 + vascular endothelial cells.
Discussion
OX40 was first identified on activated rat CD4 + T cells (40) . During the past several years, cDNAs encoding rat, mouse, and human OX40 have been cloned (41, 56, 57) . It gp34, the ligand of OX40, was previously described as a surface molecule expressed on certain H T L V -I -i n f e c t e d T cell fines (44) (45) (46) . Although it is k n o w n that gp34 is expressed in multiple organs such as heart, skeletal muscle, testis, and activated B cells (42) , expression o f g p 3 4 in vail- ous tissues and cell types has not been investigated in detail.
Here we report for the first time that human vascular endothelial cells including HUVECs, HAECs, and HDMECs, express gp34 without stimulation in vitro. Furthermore, we showed that not only anti-OX40 mAb but also antigp34 mAb inhibited binding of ATL-43T to HUVECs, indicating that the OX40/gp34 system participates in cell adhesion.
As to the mechanism of cell adhesion mediated by the OX40/gp34 system, the following possibility should be taken into consideration. OX40/gp34 interaction may generate stimulatory signals resulting in increased binding activity of the other existing adhesion molecules. Indeed, Hollenbaugh et al. (62) have reported that the interaction of CD40 expressed on vascular endothelial cells with its ligand can lead to endothelial cell activation, which in turn leads to leukocyte adhesion through the upregulation of ICAM-1, VCAM-1, or E-selectin. A similar explanation also seems possible with the OX40/gp34 system. Nevertheless, it is rather unlikely that the major part of cell adhesion shown in this study is indirectly mediated by stimulatory signals through the OX40/gp34 system. First, incubation time in adhesion assay is too short to cause a quantitative change in expression of other adhesion molecules. Second, cell adhesion mediated by OX40 and gp34 could be reconstructed in OX40-transfected Kit 225 and gp34-transfected MMCE, a mouse epithelial cell line lacking human ICAM-1, VCAM-1, and E-selectin. This adhesion was specifically inhibited by anti-OX40 or anti-gp34 mAb. Finally, paraformaldehydefixed ATL-43T cells still showed modest but significant binding to nonfixed or fixed HUVECs, which was inhibited by anti-OX40 as well as anti-gp34 mAb.
It is now realized that cell adhesion is a multistep process involving ligand receptor recognition and subsequent cellular activation. Most of the adhesion molecules themselves have recently been shown to transmit activation signals (29) (30) (31) . A number of cytokines and costimulatory molecules are also involved in this process by upregulating expression or bindability of adhesion molecules. However, there is another aspect of the ligand receptor interaction: the intercellular binding between membrane molecules is always accompanied by physical cell-to-cell binding. Accordingly, it is rather natural to presume that binding of a membrane-bound molecule to its ligand or receptor contributes to cell-to-cell binding to some extent, whether or not this contribution can be detected, depending on the assay system and coexistence of other adhesion molecules. Our study presents such an interesting case in which a cytokine receptor-like molecule, OX40, and its ligand, gp34, can directly mediate cell adhesion. Remodeling of the concepts of adhesion and costimulatory molecules will be required to reconcile these results.
T cell recruitment has been investigated based on the Figure 11 . Adhesion between ATL-43T and HUVECs after fixation with paraformaldehyde. ATL-43T cells, unfixed or fixed with 0.4% paraformaldehyde for 10 rain at room temperature, were preincubated with 10 ~g/rnl of W6/32 (anti-MHC class I mAb), 315 (anti-OX40 mAb), or 5A8 (anti-gp34 mAb) and then their binding to HUVECs, unfixed or fixed with 0.4% paraformaldehyde, was measured.
hypothesis that several pairs of homing receptors and vascular addressins mediate adhesion of lymphoid cells to endothehal cells and regulate their localization. Therefore, tissue specificity of the homing of T cell subsets is thought to be determined predominantly by cell type-or tissue-specific expression of a certain set of adhesion molecules including integrins, Ig superfamily, and selectins. The OX40/gp34 system seems to define a distinct pathway of T cell recruitment that is independent of the tissue specificity or the conditions of tissue environment, affecting any type of activated CD4 + T cells. It may be complementary to the conventional tissue-specific cell adhesion, especially in situations where a significant proportion of circulating T cells are activated and express OX40. Finally, the present study reemphasizes the importance of vascular endothelial cells for distribution and activation of T cells. It is very hkely that interaction between T cells and vascular endothehal cells via OX40 and gp34 generates activation signals to both sides in addition to the physical cell adhesion. Further studies are required to delineate its physiologic as well as pathologic meanings and the roles of vascular endothelial cells during this interaction for the better understanding of immune response in vivo.
